Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03476447 · ClinicalTrials.gov registry record · NA
Rescuing the Microbiome Effectively With Different Doses of B. Infantis in Infants
A NA study, sponsored by Evolve BioSystems.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03476447 is a NA study that has completed, run by Evolve BioSystems. The registered enrollment target is 40 participants.
The verdict
NCT03476447, a NA study, has completed, sponsored by Evolve BioSystems.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The REMEDI Study is a single-center, prospective, double-blind, randomized, placebo-controlled trial of multiple doses of B. infantis EVC001 supplementation in healthy term breastfed infants.
Interventions
- OTHER B. infantis EVC001
- OTHER Lactose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-04-06 |
| Est. Completion | 2019-04-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03476447
The ClinicalTrials.gov registry entry for NCT03476447 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Evolve BioSystems, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which B. infantis EVC001 is the first listed.
NCT03476447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03476447 about?
NCT03476447 is a clinical study titled "Rescuing the Microbiome Effectively With Different Doses of B. Infantis in Infants". The REMEDI Study is a single-center, prospective, double-blind, randomized, placebo-controlled trial of multiple doses of B. infantis EVC001 supplementation in healthy term breastfed infants.
What is the current status of trial NCT03476447?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-04-06. Estimated completion is 2019-04-03.
What interventions are being tested in trial NCT03476447?
The interventions under investigation include: B. infantis EVC001 (OTHER), Lactose (OTHER).
Who is sponsoring clinical trial NCT03476447?
This trial is sponsored by Evolve BioSystems, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.